More state Medicaid programs consider covering GLP-1 drugs for obesity! Luro Health is excited to see states recognizing the long-term benefits of weight management solutions for Medicaid populations. While the upfront costs of GLP-1, and drugs may seem high, the downstream health benefits can ultimately drive healthcare savings. Reducing obesity through effective interventions can lower the incidence of costly chronic conditions, aligning perfectly with our mission to bring scalable, evidence-based obesity care to underserved communities. https://lnkd.in/gptx4shv #HealthcareInnovation #ObesityManagement #Medicaid #NACHC
Luro Health
健康与公共事业
Luro Health virtualizes obesity & weight management programs for Federally Qualified and Community Health Centers.
关于我们
Luro Health virtualizes obesity centers of excellence for Federally Qualified Health Centers (FQHCs) and Community Health Centers (CHCs) by integrating advanced AI tools alongside white-labeled care delivery. These centers support the largest underserved patient populations with obesity and with Luro Health will have the infrastructure to support patients with obesity, identify at-risk individuals, customize treatment plans, and monitor patient progress effectively through AI-driven solutions.
- 网站
-
https://www.lurohealth.com/
Luro Health的外部链接
- 所属行业
- 健康与公共事业
- 规模
- 2-10 人
- 类型
- 私人持股
- 创立
- 2024